Zhen Su

Zhen Su

Company: Marengo Therapeutics

Job title: Chief Executive Officer

Seminars:

Novel Biomarker Strategy for Next Wave IO Therapeutics 10:55 am

• Innovative development strategies to facilitate clinical investigation of novel IO therapeutics • Clinical validation and integration of multiple predictive biomarkers within tumor cells and the TME • Development of multifactorial synergistic predictive biomarkers to identify immunotherapy efficacyRead more

day: Day 1 red

Clinical Biomarker Development
Track Chair: 10:00 am

Read more

day: Day 1 red

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.